ADAMM Q1 2026 Earnings Strong EPS Beat Driven by Investment Income Tenaya Therapeutics Q1 2026 Earnings Narrow Miss on Earnings as Biotech Firm Reports No Revenue SLM Q1 2026 Earnings EPS Surges Past Estimates on Strong Credit and Cost Control NOK Q1 2026 Earnings EPS Surprises to the Upside as Stock Declines Reliance Global Group Q1 2023 Earnings Surprise Profitability Defies Estimates Turn Therapeutics TTRX Q1 2026 Earnings Narrow EPS Miss Amid Modest Stock Gains